Gyro International has acquired UK marketing consultancy Woolley Pau, marking the latest effort in the B2B agency’s quest to become the largest independent communications agency in the world.
Woolley Pau, a healthcare and biotech specialist working on brands that include over-the-counter and prescription medicines, has been purchased for an undisclosed sum. It has a staff count of 25 and an annual turnover of around £3 million.
Gyro has made no secret of the fact it wishes to expand its range of vertical markets, and is also on the verge of closing deals with another healthcare agency, a client in the energy sector and a research company. It has already purchased bio-chemical experts Cicero and bio-technology specialist Dowell Stubbs this year.
Richard Glasson, chief operating officer at Gyro International, confirms that another healthcare acquisition is on target to be completed “before Christmas.”
“Strategically, Woolley Pau is a significant acquisition for Gyro. We have identified healthcare as a key market for growth and we are extremely close to being able to offer our clients a total healthcare offering,” he says.
Louisa Pau, Woolley Pau’s joint founder and MD, adds, “We have a fantastic reputation for creativity, but until now we’ve lacked the global stature and group resources to compete consistently with the healthcare networks. While the scale of our offering has undoubtedly changed, for us it’s fundamentally business as usual. For our existing and potential clients, it’s a case of Woolley Pau and then some.”
The new acquisition takes Gyro’s total staff count to over 300, 183 of which are based in London.
Related articles
Gyro expands European presence with new acquisition – 09-07-07
Or use our enhanced search functionality to find other related articles
